Pancreatic Islet Storage Medium Using ECM Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for storing isolated pancreatic islets fail to maintain their secretory properties at both physiological and refrigerated temperatures, leading to potential damage and loss of function due to the disruption of extracellular matrix components during storage.
Innovation Solution
A medium is developed using CMRL 1066 or RPMI as a base, supplemented with specific proportions of extracellular matrix proteins such as laminin, hyaluronic acid, collagen I, and collagen IV, along with optional additives like cryoprotectants and serum, to create an environment that mimics the natural ECM, thereby preserving the islets' functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional storage media are used for isolated pancreatic islets, then storage is possible, but the secretory properties and functionality of the islets deteriorate over time
Solution Approach 1:
The patent introduces an intermediary substance (extracellular matrix components such as collagen, fibronectin, laminin, and hyaluronic acid) that mediates between the storage medium and the pancreatic islets. These ECM components mimic the natural microenvironment, providing biochemical and structural support that maintains islet functionality during storage without requiring complex living conditions.
Solution Approach 2:
The patent optimizes specific parameters of the storage medium including the concentrations of ECM components (collagen 0.1-1.0 mg/mL, fibronectin 0.01-0.5 mg/mL, laminin 0.01-0.5 mg/mL, hyaluronic acid 0.01-0.1 mg/mL), pH (7.0-7.4), temperature (2-8°C), and osmolarity (270-300 mOsm/kg) to achieve optimal preservation of islet secretory properties throughout the storage period.
2Duration of action of stationary object
If refrigerated storage at 4°C is used, then storage duration is extended, but the secretory properties of islets are damaged
Solution Approach 1:
The patent applies beforehand cushioning by pre-cooling the ECM-containing storage medium to refrigeration temperatures before contact with the islets, and by selecting cold-stable ECM components that maintain their structural and biochemical integrity at 4°C. This prevents thermal shock and cold-induced denaturation of the islets while extending storage duration.
3Reliability
If physiological temperature storage at 37°C is used, then secretory properties are maintained, but storage duration is limited
Solution Approach 1:
The patent enables continuity of useful action by providing a storage medium that maintains islet metabolic activity and secretory function at physiological temperature (37°C) throughout the storage period. The ECM components continue to provide biochemical signals and structural support, allowing the islets to remain in a functional state rather than being merely preserved.
4Reliability
If extracellular matrix components are added to the storage medium, then islet functionality is improved, but the complexity of the medium increases
Solution Approach 1:
The patent uses composite materials by combining multiple ECM components (collagen, fibronectin, laminin, hyaluronic acid) in specific ratios within a single storage medium formulation. This composite approach synergistically enhances islet functionality while maintaining a unified, manageable medium composition that can be prepared and stored as a single solution.
Data Source
AI summary
The invention relates to a medium for storing isolated pancreatic islets and a method for storing isolated pancreatic islets. Such a medium is suitable for storing pancreatic islets both at physiological temperature and refrigerated.